MedTrace Logo

Clinical Evaluation of the Adaptilens Accommodating IOL

NCT07607860 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-06

No results posted yet for this study

Summary

The goals of this feasibility study are to learn more about the performance of the intraocular lens (IOL), if the IOL is safe for use, and what the best surgical techniques are for implanting the IOL in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract.

Conditions

  • Aphakia Cataract

Interventions

DEVICE

Accomodating Intra Ocular Lens

This lens is accommodating.

DEVICE

Monofocal Intra Ocular Lens

Monofocal lens

Sponsors & Collaborators

  • Adaptilens, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07607860 on ClinicalTrials.gov